메뉴 건너뛰기




Volumn 3, Issue 7, 2012, Pages 752-762

M1 muscarinic cetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease

Author keywords

[No Author keywords available]

Indexed keywords

1 (1' 2 METHYLBENZYL) 1,4' BIPIPERIDIN 4 YL 1H BENZO[D]IMIDAZOL 2(3H) ONE; 1 BENZYLINDOLINE 2,3 DIONE DERIVATIVE; 77 LH 28 1; AC 42; AE 51090; BENZIMIDAZOLE DERIVATIVE; INDOL 3 YLSULFONYLACETAMIDE DERIVATIVE; MUSCARINIC M1 RECEPTOR AGONIST; QUINOLONE CARBOXYLIC ACID DERIVATIVE; THRX 160209; UNCLASSIFIED DRUG; VU 0029767; VU 00405652; VU 0090157; VU 0119498; VU 0357017; VU 0366369; XANOMELINE;

EID: 84863635488     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c2md20025b     Document Type: Review
Times cited : (20)

References (74)
  • 58
    • 84863694157 scopus 로고    scopus 로고
    • WO Pat., 2009051715
    • S. D. Kuduk and R. K. Chang, WO Pat., 2009051715, 2009
    • (2009)
    • Kuduk, S.D.1    Chang, R.K.2
  • 74
    • 79960343607 scopus 로고    scopus 로고
    • http://www.dementia2010.org/
    • A. Abbott Nature 2011 475 S2 S3
    • (2011) Nature , vol.475
    • Abbott, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.